Europe Diabetes Devices Market to Reach $12.4 Billion by 2031, Driven by Diabetes Incidence & Continuous Glucose Monitoring Uptake

Leander, Texas, United States - Nov.20.2025
As per DataM intelligence research report" Europe Diabetes Devices Market reached US$ 9.2 billion in 2023 and is expected to reach US$ 12.4 billion by 2031, growing at a CAGR of 8.7% during the forecast period 2024-2031.". Rising diabetes prevalence and technological innovation are fueling adoption of advanced diabetes management devices in Europe.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/europe-diabetes-devices-market?sp

Europe: Recent Industry Developments

✅ In November 2025, Roche Diabetes Care launched its next-generation continuous glucose monitoring (CGM) system across European markets, featuring AI-driven trend prediction and smartphone integration. The device improves glycemic control and patient convenience. This reinforces Roche's leadership in Europe's diabetes device sector.

✅ In October 2025, Medtronic Europe invested €28 million to expand production of insulin pumps and hybrid closed-loop systems for adults and pediatric patients. The investment addresses rising demand for automated diabetes management solutions. This strengthens Medtronic's presence in Europe's advanced diabetes care market.

✅ In September 2025, Novo Nordisk partnered with Senseonics to deploy implantable CGM systems in selected European countries, offering long-term glucose monitoring with minimal calibration. The collaboration enhances precision diabetes care and patient adherence. This highlights Novo Nordisk's focus on integrated diabetes technology solutions.

✅ In August 2025, Dexcom Europe launched software updates for its G7 CGM platform, adding predictive analytics and remote monitoring features for clinicians. The updates aim to improve early intervention and treatment personalization. This development reinforces Dexcom's innovation leadership in Europe's diabetes device market.

Europe Diabetes Devices Market: Drivers

The Europe diabetes devices market is witnessing strong growth as the prevalence of diabetes continues to rise across the region, driven by lifestyle changes, aging populations, and increasing awareness of the disease. Diabetes devices, including glucose monitors, continuous glucose monitoring (CGM) systems, insulin pumps, and smart pens, play a critical role in blood sugar management, insulin delivery, and patient self-care. Technological advancements in wearable sensors, non-invasive monitoring, wireless connectivity, and AI-powered data analytics are enhancing device accuracy, usability, and real-time health insights. Additionally, growing adoption of home-based monitoring solutions, telemedicine integration, and patient-centric care programs is supporting market expansion.

Collaborations between device manufacturers, healthcare providers, and research institutions are accelerating the development and commercialization of advanced diabetes management solutions. Regulatory support, reimbursement policies, and government initiatives promoting chronic disease management are encouraging broader adoption across hospitals, clinics, and home care settings. Increasing focus on personalized treatment plans, digital health platforms, and data-driven disease management is driving demand for connected and integrated devices. Rising consumer awareness, lifestyle management programs, and preventive healthcare initiatives are further boosting market growth. With continuous innovation, technological integration, and rising prevalence of diabetes, the Europe diabetes devices market is poised for sustained expansion.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/europe-diabetes-devices-market?sp

Europe Diabetes Devices Market: Major Players

Novo Nordisk A/S, Abbott Laboratories, Nipro Medical Europe, Afon Technology Ltd, GlucoRx Limited, Ascensia Diabetes Care UK Limited, SIBIONICS, Roche Diabetes Care, Kinetik Medical Devices Limited AND Dexcom, Inc. among others.

Segment Covered in the Europe Diabetes Devices Market:

By Device Type
Blood glucose monitoring (BGM) devices dominate the Europe diabetes devices market with 58% share, driven by widespread self-monitoring adoption, continuous glucose monitoring (CGM) advancements, and rising diabetes prevalence across major EU countries. Insulin delivery devices hold 34%, supported by strong uptake of insulin pens, smart pumps, and patch pumps offering greater convenience and dosing accuracy. Other device types collectively account for 8%, including emerging digital management solutions and adjunct monitoring tools designed to improve disease tracking and patient compliance.

By Distribution Channel
Retail pharmacies lead with 39% share, supported by high accessibility, wide product availability, and strong patient preference for in-person guidance. Hospital pharmacies account for 27%, driven by prescription-based device dispensing, inpatient diabetes care, and post-diagnosis support. Diabetes clinics and centers hold 18%, playing a critical role in structured disease management and continuous monitoring programs. Online pharmacies capture 12%, growing rapidly due to subscription refills, convenience, and digital diabetes care platforms. Other channels represent 4%, including specialty suppliers and institutional purchasing networks.

Regional Analysis - Europe
Western Europe dominates with 62% share, led by Germany, the U.K., France, Italy, and Spain, where strong reimbursement systems and advanced diabetes care infrastructure support rapid device adoption. Northern Europe holds 18%, driven by early adoption of CGM and insulin pump technologies across the Nordics. Eastern Europe accounts for 14%, with rising diabetes prevalence and expanding access to modern monitoring devices. Southern and other parts of Europe collectively hold 6%, supported by improving healthcare facilities and growing awareness of technology-assisted diabetes management.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=europe-diabetes-devices-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.